A month and a half after hospitals were mandated to show their prices for shoppable services, anecdotal evidence shows some may be deeming the penalty of up to $300 per day insufficiently incentivizing.

The government of Saudi Arabia is bringing in Royal Philips to help the country of 35 million become a global leader in healthcare AI.

A new alliance of powerful associations representing providers, payers, hospitals and employers has formed to push U.S. healthcare toward universal coverage.

At a list price of $86,000 per month, Zokinvy is right now the costliest medication in the U.S. that patients can self-administer.

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.

Hospital leaders discouraged by COVID-19’s devastating toll on human life and wellbeing must also mind the price the crisis is exacting on their organization’s financial health.